No. |
DrugBank |
薬物名(臨床試験情報から抽出) |
KEGG DRUG * | KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 | Avacincaptad pegol | 1件: Avacincaptad pegol; | - |
- |
- |
1件: 301 |
2 | Cholesterol | 9件: 3h-cholesterol bound to albumin; Cholesterol; Cholesterol supplementation; Crystalline cholesterol oil-based suspension; Egg substitute, without cholesterol; Egg yolk preparation with cholesterol; Lysosomal acid lipase, esterase, cholesterol (human gene lipa), lysosomal acid lipase (human gene lipa); Recombinant human lysosomal acid lipase (rhlal), esterase, cholesterol (human gene lipa); Recombinant human lysosomal acid lipase (rhlal), esterase, cholesterol (human gene lipa), lysosomal acid lipase (human gene lipa); | D00040 |
- |
- |
7件: 19, 90, 160, 259, 261, 301, 310 |
3 | Doconexent | - | - |
- |
- |
7件: 6, 49, 90, 94, 240, 299, 301 |
4 | Emixustat | 3件: Emixustat; Emixustat hydrochloride; Emixustat hydrochloride (acu-4429); | D10348 |
- |
- |
1件: 301 |
5 | Fomepizole | - | D00707 |
3件: ADH1A, ADH1B, ADH1C |
8件: Chemical carcinogenesis, Drug metabolism - cytochrome P450, Fatty acid degradation, Glycolysis / Gluconeogenesis, Metabolic pathways, Metabolism of xenobiotics by cytochrome P450, Retinol metabolism, Tyrosine metabolism |
1件: 301 |
6 | Interferon gamma-1b | 2件: Interferon gamma-1b; Interferon gamma-1b (actimmune); | D00747 |
2件: IFNGR1, IFNGR2 |
19件: Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Salmonella infection, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
7件: 65, 85, 90, 228, 299, 301, 326 |
7 | Ranibizumab | 3件: Intravitreal injection ranibizumab; Ranibizumab; Ranibizumab injection (0.5 mg); | D05697 |
1件: VEGFA |
21件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway |
4件: 34, 166, 227, 301 |